379 results on '"Sasaki, Hikaru"'
Search Results
2. Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
3. Disturbance Injection under Partial Automation: Robust Imitation Learning for Long-horizon Tasks
4. Bayesian Disturbance Injection: Robust Imitation Learning of Flexible Policies for Robot Manipulation
5. Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
6. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy
7. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
8. Duality Cascades and Parallelotopes
9. Disturbance-Injected Robust Imitation Learning with Task Achievement
10. Gaussian Process Self-triggered Policy Search in Weakly Observable Environments
11. Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
12. Variational Policy Search using Sparse Gaussian Process Priors for Learning Multimodal Optimal Actions
13. Bayesian Disturbance Injection: Robust Imitation Learning of Flexible Policies
14. Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence
15. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.
16. Learning Re-grabbing Policies based on Grabbed Garbage Weight Estimation using In-bucket Images for Waste Cranes
17. Bayesian Disturbance Injection: Robust imitation learning of flexible policies for robot manipulation
18. The role of optimal cut-off diagnosis in 11C-methionine PET for differentiation of intracranial brain tumor from non-neoplastic lesions before treatment
19. The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas
20. A common deletion at BAK1 reduces enhancer activity and confers risk of intracranial germ cell tumors
21. Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy
22. Molecular investigation of brain tumors progressing during pregnancy or postpartum period: the association between tumor type, their receptors, and the timing of presentation
23. A case of central nervous system lesion pathologically characterized by angiocentric, T-cell-rich lymphoid cell infiltrates: a case report and literature review
24. Layer dependence in strain distribution and chondrocyte damage in porcine articular cartilage exposed to excessive compressive stress loading
25. Immunohistochemistry for O6-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients’ progression-free survival with the cut-off value determined by ROC analysis
26. Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion
27. Association of preoperative seizures with tumor metabolites quantified by magnetic resonance spectroscopy in gliomas
28. c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas
29. Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma
30. 10005-ANGI-1 REGULATION OF ALTERNATIVE ANGIOGENIC FACTORS IN BEVACIZUMAB THERAPY FOR GLIOBLASTOMA
31. 10001-ACT-1 A MULTICENTER EXPLORATORY PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT GLIOMA - THE SECOND REPORT
32. SURG-01. DIFFERENTIATION OF GLIOBLASTOMA AND MALIGNANT MENINGIOMA FROM NORMAL BRAIN BY TISSUE STIFFNESS UTILIZING MICROSURGICAL FORCEPS EQUIPPED WITH HAPTICS TECHNOLOGY
33. EXTH-01. STEM CELL THERAPY FOR LEPTOMENINGEAL DISEASE
34. CTNI-45. UPFRONT CHEMOTHERAPY AND SUBSEQUENT RESECTION UTILIZING NEOADJUVANT STRATEGY FOR OLIGODENDROGLIOMAS
35. Preoperative Prediction of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Magnetic Resonance Imaging Texture Analysis
36. Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma
37. Pros and cons of using ORBEYE™ for microneurosurgery
38. Tumor immune microenvironment is associated with the growth of intracranial germinomas
39. Predictive markers for MGMT promoter methylation in glioblastomas
40. Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis
41. Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas
42. コウカケイ ダイガクセイ ノ コミュニケーション ノ ケイジテキ ヘンカ ト メンタルヘルス ノ カンケイ
43. ニュウガク ショキ ノ ガクギョウ ヘノ ツマズキ カン オヨビ シンリテキ リスク ト セイシンテキ フケンコウ オヨビ ダイガクセイカツ ノ ジュウジツカン テイカ ノ ハッセイ リスク
44. An exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma
45. Correction to: Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
46. Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series
47. Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma
48. JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma
49. 原発性悪性脳腫瘍に対する光線力学的療法:慶應義塾大学病院における初期治療経験
50. The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.